Fundraising FoxVisano Theranostics
1 known investors
Find your way into Visano Theranostics
Sign up to see every warm intro you have to Visano Theranostics
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Visano Theranostics team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Visano Theranostics develops PSMA-targeted nanobubble contrast agents that add real-time molecular imaging to standard ultrasound workflows for the diagnosis and treatment of prostate cancer. The company licensed nanobubble technologies from Case Western Reserve University and is focused on precision oncology for prostate cancer.
Founders & leadership
Investors · 1
Frequently asked questions
- What does Visano Theranostics do?
- Visano Theranostics develops PSMA-targeted nanobubble contrast agents that add real-time molecular imaging to standard ultrasound workflows for the diagnosis and treatment of prostate cancer. The company licensed nanobubble technologies from Case Western Reserve University and is focused on precision oncology for prostate cancer.
- Who founded Visano Theranostics?
- Visano Theranostics was founded by James P. Basilion, Agata A. Exner, Michael J. Haag.
- Who are Visano Theranostics's investors?
- Visano Theranostics's investors include JumpStart Equity.